addex pharmaceuticals ltd deal struck with merck to fuel drug research addex pharmaceuticals ltd said it entered an exclusive collaboration and license agreement with merck &amp co to develop a new class of drugs to treat parkinsons disease and potentially other illnesses for as much as &# million in upfront and milestone payments addex said it will receive &# million up front from merck and is eligible for research development and regulatory milestone payments of up to &# million for the first drug developed with multiple indications 
